跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RAVICTI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RAVICTI
Authorized
STANDARD
RAVICTI
HORIZON THERAPEUTICS IRELAND DAC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
c717adc014429fc0
Company
HORIZON THERAPEUTICS IRELAND DAC
Type
Standard
Approval Details
Approval Id
c717adc014429fc0
Drug Approval Canada Name
RAVICTI
Product Name
RAVICTI
Status
Marketed
Status Date
2016-11-03
Original Market Date
2016-11-03
Din
02453304
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Oral
Schedule
Prescription
Atc Original
A16AX09 GLYCEROL PHENYLBUTYRATE
Atc Name
a 16 ax 09
Aig Number
0157990001
Company Name
HORIZON THERAPEUTICS IRELAND DAC
Company Address
Pottery Road, Dun Laoghaire Co. Dublin, Dublin, Ireland, A96F2A8
Company Detail Path
/organization/horizon-therapeutics-ireland-dac
Company Information
Pharmaceutical Company Name
Horizon Therapeutics Ireland DAC
Name En
Horizon Therapeutics Ireland DAC
Country Name
Spain
Province Name
Madrid
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA 66
Active Ingredients
GLYCEROL PHENYLBUTYRATE
1.1 G / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
c717adc014429fc0
Type
Standard
Back to Health Canada Approvals